Why the study?
SFKs are connected with cardiovascular homeostasis and modulate various cardiac pathologies, but an updated summary of their mechanisms, roles in CVDs, and potential as biomarkers and therapeutic targets was needed.
Key points are not available for this paper at this time.
Design
Narrative review
Answers are grounded in this paper and cite their sources.
SFK signaling supports cardiac homeostasis under stress; leaves open targeted modulation in cardiovascular disease.
The Src-family protein tyrosine kinases (SFKs), a subfamily of non-receptor tyrosine kinases, are ubiquitously expressed in various cell types. Numerous studies have suggested that SFKs are related to signal transduction in major cardiac physiological and pathological processes, it is the activity of SFKs that is connected with the maintenance of cardiovascular homeostasis. Upon stimulation of various injury factors or stress, the phosphorylation state of SFKs is changed, which has been found to modulate different cardiac pathological conditions, such as hypertension, coronary heart disease, ischemic heart disease, myocardial ischemia-reperfusion injury, arrhythmia and cardiomyopathy via regulating cell growth, differentiation, movement and function, electrophysiologic signals. This review summarizes the basic information about SFKs, updates its role in the different processes underlying the development of multiple cardiovascular diseases (CVDs), and highlights their potential role as disease biomarkers and therapeutic targets, which would help understand the pathophysiology of CVDs and promote the further potential clinical adhibition.
No takes yet. Share an insight, caveat, or question.
Zhai et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: